Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.

Identifieur interne : 000134 ( Main/Corpus ); précédent : 000133; suivant : 000135

COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.

Auteurs : Cong Ye ; Jixin Zhong ; Shaozhe Cai ; Li Dong ; Chuanjing Li ; Xiaoqiang Hou ; Xiaoqi Chen ; Anbing Zhang ; Wenli Chen ; Dongchu He ; Tao Zhou ; Guilian Shang ; Aichun Chu ; Huiling Li ; Qihuan Liu ; Bin Wu ; Xiangdong Yu ; Tao Peng ; Cheng Wen ; Gang Hong Huang ; Hao Huang ; Qin Huang ; Linchong Su ; Wenping Chen ; Huiqin Yang ; Lingli Dong

Source :

RBID : pubmed:33821253

Abstract

Novel Coronavirus disease 2019 (COVID-19) has spread rapidly around the world. Individuals with immune dysregulation and/or on immunosuppressive therapy, such as rheumatic patients, are considered at greater risk for infections. However, the risks of patients with each subcategory of rheumatic diseases have not been reported. Here, we identified 100 rheumatic patients from 18,786 COVID-19 patients hospitalized in 23 centers affiliated to Hubei COVID-19 Rheumatology Alliance between January 1 and April 1, 2020. Demographic information, medical history, length of hospital stay, classification of disease severity, symptoms and signs, laboratory tests, disease outcome, computed tomography, and treatments information were collected. Compared to gout and ankylosing spondylitis (AS) patients, patients with connective tissue disease (CTD) tend to be more severe after COVID-19 infection (= 0.081). CTD patients also had lower lymphocyte counts, hemoglobin, and platelet counts (p values were 0.033, < 0.001, and 0.071, respectively). Hydroxychloroquine therapy and low- to medium-dose glucocorticoids before COVID-19 diagnosis reduced the progression of COVID-19 to severe/critical conditions (= 0.001 for hydroxychloroquine; = 0.006 for glucocorticoids). Our data suggests that COVID-19 in CTD patients may be more severe compared to patients with AS or gout.

DOI: 10.1002/mco2.56
PubMed: 33821253
PubMed Central: PMC8013216

Links to Exploration step

pubmed:33821253

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.</title>
<author>
<name sortKey="Ye, Cong" sort="Ye, Cong" uniqKey="Ye C" first="Cong" last="Ye">Cong Ye</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhong, Jixin" sort="Zhong, Jixin" uniqKey="Zhong J" first="Jixin" last="Zhong">Jixin Zhong</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cai, Shaozhe" sort="Cai, Shaozhe" uniqKey="Cai S" first="Shaozhe" last="Cai">Shaozhe Cai</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dong, Li" sort="Dong, Li" uniqKey="Dong L" first="Li" last="Dong">Li Dong</name>
<affiliation>
<nlm:affiliation>Jingzhou City Central Hospital of Hubei Province Jingzhou Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Li, Chuanjing" sort="Li, Chuanjing" uniqKey="Li C" first="Chuanjing" last="Li">Chuanjing Li</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology Xiaogan Hospital Affiliated to Wuhan University of Science and Technology Xiaogan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hou, Xiaoqiang" sort="Hou, Xiaoqiang" uniqKey="Hou X" first="Xiaoqiang" last="Hou">Xiaoqiang Hou</name>
<affiliation>
<nlm:affiliation>The First College of Clinical Medical Sciences China Three Gorges University Yichang Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chen, Xiaoqi" sort="Chen, Xiaoqi" uniqKey="Chen X" first="Xiaoqi" last="Chen">Xiaoqi Chen</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology Zhongnan Hospital of Wuhan University Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Anbing" sort="Zhang, Anbing" uniqKey="Zhang A" first="Anbing" last="Zhang">Anbing Zhang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Xiangyang Central Hospital Xiangyang Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chen, Wenli" sort="Chen, Wenli" uniqKey="Chen W" first="Wenli" last="Chen">Wenli Chen</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Wuhan Central Hospital Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="He, Dongchu" sort="He, Dongchu" uniqKey="He D" first="Dongchu" last="He">Dongchu He</name>
<affiliation>
<nlm:affiliation>Department of Integrated Treatment General Hospital of Central Theater Command Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Tao" sort="Zhou, Tao" uniqKey="Zhou T" first="Tao" last="Zhou">Tao Zhou</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shang, Guilian" sort="Shang, Guilian" uniqKey="Shang G" first="Guilian" last="Shang">Guilian Shang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tianyou Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chu, Aichun" sort="Chu, Aichun" uniqKey="Chu A" first="Aichun" last="Chu">Aichun Chu</name>
<affiliation>
<nlm:affiliation>Department of Prevention and Health Care Renmin Hospital of Wuhan University Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Li, Huiling" sort="Li, Huiling" uniqKey="Li H" first="Huiling" last="Li">Huiling Li</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology The Traditional Chinese Medical Hospital of Hubei Province Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Liu, Qihuan" sort="Liu, Qihuan" uniqKey="Liu Q" first="Qihuan" last="Liu">Qihuan Liu</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Affliated Dongfeng Hospital Hubei University of Medicine Shiyan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wu, Bin" sort="Wu, Bin" uniqKey="Wu B" first="Bin" last="Wu">Bin Wu</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology The First People's Hospital of Jingzhou Jingzhou Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yu, Xiangdong" sort="Yu, Xiangdong" uniqKey="Yu X" first="Xiangdong" last="Yu">Xiangdong Yu</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Huangshi Central Hospital of Edong Healthcare Group Huangshi Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Peng, Tao" sort="Peng, Tao" uniqKey="Peng T" first="Tao" last="Peng">Tao Peng</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Hankou Hospital of Wuhan Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wen, Cheng" sort="Wen, Cheng" uniqKey="Wen C" first="Cheng" last="Wen">Cheng Wen</name>
<affiliation>
<nlm:affiliation>Department of Endocrinology Xiaogan First People's Hospital Xiaogan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Huang, Gang Hong" sort="Huang, Gang Hong" uniqKey="Huang G" first="Gang Hong" last="Huang">Gang Hong Huang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology China Resources and Wisco General Hospital Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Huang, Hao" sort="Huang, Hao" uniqKey="Huang H" first="Hao" last="Huang">Hao Huang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology The First People's Hospital of Tianmen Tianmen Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Huang, Qin" sort="Huang, Qin" uniqKey="Huang Q" first="Qin" last="Huang">Qin Huang</name>
<affiliation>
<nlm:affiliation>Department of Nephrology and Rheumatology Enshi Tujia and Miao Autonomous Prefecture Central Hospital Enshi Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Su, Linchong" sort="Su, Linchong" uniqKey="Su L" first="Linchong" last="Su">Linchong Su</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Minda Hospital of Hubei Minzu University Enshi Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chen, Wenping" sort="Chen, Wenping" uniqKey="Chen W" first="Wenping" last="Chen">Wenping Chen</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Huanggang Central HospitaI Huanggang Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yang, Huiqin" sort="Yang, Huiqin" uniqKey="Yang H" first="Huiqin" last="Yang">Huiqin Yang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Wuhan No.1 Hospital Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dong, Lingli" sort="Dong, Lingli" uniqKey="Dong L" first="Lingli" last="Dong">Lingli Dong</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33821253</idno>
<idno type="pmid">33821253</idno>
<idno type="doi">10.1002/mco2.56</idno>
<idno type="pmc">PMC8013216</idno>
<idno type="wicri:Area/Main/Corpus">000134</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000134</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.</title>
<author>
<name sortKey="Ye, Cong" sort="Ye, Cong" uniqKey="Ye C" first="Cong" last="Ye">Cong Ye</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhong, Jixin" sort="Zhong, Jixin" uniqKey="Zhong J" first="Jixin" last="Zhong">Jixin Zhong</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cai, Shaozhe" sort="Cai, Shaozhe" uniqKey="Cai S" first="Shaozhe" last="Cai">Shaozhe Cai</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dong, Li" sort="Dong, Li" uniqKey="Dong L" first="Li" last="Dong">Li Dong</name>
<affiliation>
<nlm:affiliation>Jingzhou City Central Hospital of Hubei Province Jingzhou Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Li, Chuanjing" sort="Li, Chuanjing" uniqKey="Li C" first="Chuanjing" last="Li">Chuanjing Li</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology Xiaogan Hospital Affiliated to Wuhan University of Science and Technology Xiaogan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hou, Xiaoqiang" sort="Hou, Xiaoqiang" uniqKey="Hou X" first="Xiaoqiang" last="Hou">Xiaoqiang Hou</name>
<affiliation>
<nlm:affiliation>The First College of Clinical Medical Sciences China Three Gorges University Yichang Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chen, Xiaoqi" sort="Chen, Xiaoqi" uniqKey="Chen X" first="Xiaoqi" last="Chen">Xiaoqi Chen</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology Zhongnan Hospital of Wuhan University Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Anbing" sort="Zhang, Anbing" uniqKey="Zhang A" first="Anbing" last="Zhang">Anbing Zhang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Xiangyang Central Hospital Xiangyang Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chen, Wenli" sort="Chen, Wenli" uniqKey="Chen W" first="Wenli" last="Chen">Wenli Chen</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Wuhan Central Hospital Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="He, Dongchu" sort="He, Dongchu" uniqKey="He D" first="Dongchu" last="He">Dongchu He</name>
<affiliation>
<nlm:affiliation>Department of Integrated Treatment General Hospital of Central Theater Command Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhou, Tao" sort="Zhou, Tao" uniqKey="Zhou T" first="Tao" last="Zhou">Tao Zhou</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shang, Guilian" sort="Shang, Guilian" uniqKey="Shang G" first="Guilian" last="Shang">Guilian Shang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tianyou Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chu, Aichun" sort="Chu, Aichun" uniqKey="Chu A" first="Aichun" last="Chu">Aichun Chu</name>
<affiliation>
<nlm:affiliation>Department of Prevention and Health Care Renmin Hospital of Wuhan University Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Li, Huiling" sort="Li, Huiling" uniqKey="Li H" first="Huiling" last="Li">Huiling Li</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology The Traditional Chinese Medical Hospital of Hubei Province Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Liu, Qihuan" sort="Liu, Qihuan" uniqKey="Liu Q" first="Qihuan" last="Liu">Qihuan Liu</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Affliated Dongfeng Hospital Hubei University of Medicine Shiyan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wu, Bin" sort="Wu, Bin" uniqKey="Wu B" first="Bin" last="Wu">Bin Wu</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology The First People's Hospital of Jingzhou Jingzhou Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yu, Xiangdong" sort="Yu, Xiangdong" uniqKey="Yu X" first="Xiangdong" last="Yu">Xiangdong Yu</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Huangshi Central Hospital of Edong Healthcare Group Huangshi Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Peng, Tao" sort="Peng, Tao" uniqKey="Peng T" first="Tao" last="Peng">Tao Peng</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Hankou Hospital of Wuhan Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wen, Cheng" sort="Wen, Cheng" uniqKey="Wen C" first="Cheng" last="Wen">Cheng Wen</name>
<affiliation>
<nlm:affiliation>Department of Endocrinology Xiaogan First People's Hospital Xiaogan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Huang, Gang Hong" sort="Huang, Gang Hong" uniqKey="Huang G" first="Gang Hong" last="Huang">Gang Hong Huang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology China Resources and Wisco General Hospital Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Huang, Hao" sort="Huang, Hao" uniqKey="Huang H" first="Hao" last="Huang">Hao Huang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology The First People's Hospital of Tianmen Tianmen Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Huang, Qin" sort="Huang, Qin" uniqKey="Huang Q" first="Qin" last="Huang">Qin Huang</name>
<affiliation>
<nlm:affiliation>Department of Nephrology and Rheumatology Enshi Tujia and Miao Autonomous Prefecture Central Hospital Enshi Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Su, Linchong" sort="Su, Linchong" uniqKey="Su L" first="Linchong" last="Su">Linchong Su</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Minda Hospital of Hubei Minzu University Enshi Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chen, Wenping" sort="Chen, Wenping" uniqKey="Chen W" first="Wenping" last="Chen">Wenping Chen</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Huanggang Central HospitaI Huanggang Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yang, Huiqin" sort="Yang, Huiqin" uniqKey="Yang H" first="Huiqin" last="Yang">Huiqin Yang</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Wuhan No.1 Hospital Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dong, Lingli" sort="Dong, Lingli" uniqKey="Dong L" first="Lingli" last="Dong">Lingli Dong</name>
<affiliation>
<nlm:affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">MedComm</title>
<idno type="eISSN">2688-2663</idno>
<imprint>
<date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Novel Coronavirus disease 2019 (COVID-19) has spread rapidly around the world. Individuals with immune dysregulation and/or on immunosuppressive therapy, such as rheumatic patients, are considered at greater risk for infections. However, the risks of patients with each subcategory of rheumatic diseases have not been reported. Here, we identified 100 rheumatic patients from 18,786 COVID-19 patients hospitalized in 23 centers affiliated to Hubei COVID-19 Rheumatology Alliance between January 1 and April 1, 2020. Demographic information, medical history, length of hospital stay, classification of disease severity, symptoms and signs, laboratory tests, disease outcome, computed tomography, and treatments information were collected. Compared to gout and ankylosing spondylitis (AS) patients, patients with connective tissue disease (CTD) tend to be more severe after COVID-19 infection (
<i></i>
= 0.081). CTD patients also had lower lymphocyte counts, hemoglobin, and platelet counts (
<i>p</i>
values were 0.033, < 0.001, and 0.071, respectively). Hydroxychloroquine therapy and low- to medium-dose glucocorticoids before COVID-19 diagnosis reduced the progression of COVID-19 to severe/critical conditions (
<i></i>
= 0.001 for hydroxychloroquine;
<i></i>
= 0.006 for glucocorticoids). Our data suggests that COVID-19 in CTD patients may be more severe compared to patients with AS or gout.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">33821253</PMID>
<DateRevised>
<Year>2021</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2688-2663</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>2</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2021</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>MedComm</Title>
<ISOAbbreviation>MedComm (Beijing)</ISOAbbreviation>
</Journal>
<ArticleTitle>COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.</ArticleTitle>
<Pagination>
<MedlinePgn>82-90</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mco2.56</ELocationID>
<Abstract>
<AbstractText>Novel Coronavirus disease 2019 (COVID-19) has spread rapidly around the world. Individuals with immune dysregulation and/or on immunosuppressive therapy, such as rheumatic patients, are considered at greater risk for infections. However, the risks of patients with each subcategory of rheumatic diseases have not been reported. Here, we identified 100 rheumatic patients from 18,786 COVID-19 patients hospitalized in 23 centers affiliated to Hubei COVID-19 Rheumatology Alliance between January 1 and April 1, 2020. Demographic information, medical history, length of hospital stay, classification of disease severity, symptoms and signs, laboratory tests, disease outcome, computed tomography, and treatments information were collected. Compared to gout and ankylosing spondylitis (AS) patients, patients with connective tissue disease (CTD) tend to be more severe after COVID-19 infection (
<i></i>
= 0.081). CTD patients also had lower lymphocyte counts, hemoglobin, and platelet counts (
<i>p</i>
values were 0.033, < 0.001, and 0.071, respectively). Hydroxychloroquine therapy and low- to medium-dose glucocorticoids before COVID-19 diagnosis reduced the progression of COVID-19 to severe/critical conditions (
<i></i>
= 0.001 for hydroxychloroquine;
<i></i>
= 0.006 for glucocorticoids). Our data suggests that COVID-19 in CTD patients may be more severe compared to patients with AS or gout.</AbstractText>
<CopyrightInformation>© 2021 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ye</LastName>
<ForeName>Cong</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhong</LastName>
<ForeName>Jixin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cai</LastName>
<ForeName>Shaozhe</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Li</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Jingzhou City Central Hospital of Hubei Province Jingzhou Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Chuanjing</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology Xiaogan Hospital Affiliated to Wuhan University of Science and Technology Xiaogan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hou</LastName>
<ForeName>Xiaoqiang</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>The First College of Clinical Medical Sciences China Three Gorges University Yichang Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Xiaoqi</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology Zhongnan Hospital of Wuhan University Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Anbing</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Xiangyang Central Hospital Xiangyang Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Wenli</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Wuhan Central Hospital Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>He</LastName>
<ForeName>Dongchu</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Integrated Treatment General Hospital of Central Theater Command Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhou</LastName>
<ForeName>Tao</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Wuhan Puren Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shang</LastName>
<ForeName>Guilian</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Tianyou Hospital Affiliated to Wuhan University of Science and Technology Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chu</LastName>
<ForeName>Aichun</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Prevention and Health Care Renmin Hospital of Wuhan University Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Huiling</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology The Traditional Chinese Medical Hospital of Hubei Province Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Qihuan</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Affliated Dongfeng Hospital Hubei University of Medicine Shiyan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Bin</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology The First People's Hospital of Jingzhou Jingzhou Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Xiangdong</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Huangshi Central Hospital of Edong Healthcare Group Huangshi Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peng</LastName>
<ForeName>Tao</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Hankou Hospital of Wuhan Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wen</LastName>
<ForeName>Cheng</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Endocrinology Xiaogan First People's Hospital Xiaogan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Gang Hong</ForeName>
<Initials>GH</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology China Resources and Wisco General Hospital Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Hao</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology The First People's Hospital of Tianmen Tianmen Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Qin</ForeName>
<Initials>Q</Initials>
<AffiliationInfo>
<Affiliation>Department of Nephrology and Rheumatology Enshi Tujia and Miao Autonomous Prefecture Central Hospital Enshi Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Su</LastName>
<ForeName>Linchong</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Minda Hospital of Hubei Minzu University Enshi Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Wenping</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Huanggang Central HospitaI Huanggang Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yang</LastName>
<ForeName>Huiqin</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Wuhan No.1 Hospital Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dong</LastName>
<ForeName>Lingli</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology and Immunology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>02</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>MedComm (Beijing)</MedlineTA>
<NlmUniqueID>101769925</NlmUniqueID>
<ISSNLinking>2688-2663</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID‐19</Keyword>
<Keyword MajorTopicYN="N">SARS‐CoV‐2</Keyword>
<Keyword MajorTopicYN="N">connective tissue disease</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">rheumatic disease</Keyword>
</KeywordList>
<CoiStatement>We declare no competing interests.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>09</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2021</Year>
<Month>01</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2021</Year>
<Month>01</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>5</Hour>
<Minute>55</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33821253</ArticleId>
<ArticleId IdType="doi">10.1002/mco2.56</ArticleId>
<ArticleId IdType="pii">MCO256</ArticleId>
<ArticleId IdType="pmc">PMC8013216</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList>
<Reference>
<Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Apr;26(4):453-455</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32284614</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Rheumatol. 2020 Jul;2(7):e428-e436</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32835246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Apr;26(4):450-452</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32284615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jul;92(7):814-818</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32253759</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Rheumatol. 2020 Sep;2(9):e557-e564</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32838309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2020 Mar;16(3):133-144</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32034322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Aug;79(8):1007-1013</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32444415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2020 May;20(5):533-534</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32087114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32064853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32043983</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2020 May 1;130(5):2620-2629</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32217835</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Mar 17;323(11):1061-1069</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Omega. 2018 Dec 31;3(12):18132-18141</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30613818</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2020 Mar;16(3):155-166</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32034323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Res Ther. 2011 Aug 31;13(4):R139</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21884589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Acad Dermatol. 2020 May;82(5):e173-e175</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32224277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2017 Dec 19;14(1):7-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29255211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 Mar 26;368:m1091</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32217556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2009 Feb 18;301(7):737-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19224750</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2017 Jun;76(6):960-977</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28264816</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autoimmun. 2020 May;109:102433</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32113704</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheumatol. 2016 Jan;68(1):1-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26545940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 Apr 8;369:m1432</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32269046</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000134 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000134 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33821253
   |texte=   COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33821253" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021